About Index Trending news
Analyze
Top 50 Pricing
Akebia Therapeutics

Akebia Therapeutics

Work at Akebia Therapeutics? Add yourself to this profile

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series C)
$41,000,000
Novartis Venture Fund, Venture Investors, Novo A/S, +6
Venture capital (Series B)
$4,100,000
Novartis Venture Fund, Venture Investors, Kearny Venture Partners, +4
Employees

Unknown size

Locations
HQ
The Motley Fool

Why Epizyme Inc, Akebia Therapeutics Inc, and Cempra Inc Got Wacked Today --

Stock markets Health Costs
The Motley Fool

Why Akebia Therapeutics Shares Soared 10% Today --